Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sleep deprivation increases levels of the synaptic density marker SV2A in the human brain.

PLoS biology·2026
Same author

Prediction of cognitive performance by demographics, sleep, and brain morphometry: machine learning findings from ENIGMA-Sleep Working Group.

Research square·2026
Same author

TACR3 variant confers resilience to aging and Alzheimer's disease.

medRxiv : the preprint server for health sciences·2026
Same author

FDG PET in Movement Disorders and Parkinsonian Syndromes.

PET clinics·2026
Same author

Validation of deep-learning-based MRI-to-CT attenuation correction for striatal and extrastriatal [<sup>123</sup>I]I-FP-CIT SPECT measurement.

NeuroImage. Clinical·2026
Same author

German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025).

Nuklearmedizin. Nuclear medicine·2026
Same journal

Subcortical dopamine D<sub>2</sub> receptor availability and glucose metabolism in autism: a dual-tracer PET/MR study.

European journal of nuclear medicine and molecular imaging·2026
Same journal

PET-based assessment of coronary microvascular dysfunction and its relation to plaque burden and vascular remodeling: integration with microvascular resistance reserve.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Efficacy of peptide receptor radionuclide therapy in patients with oligodiscordant gastroenteropancreatic neuroendocrine tumours.

European journal of nuclear medicine and molecular imaging·2026
Same journal

PET imaging of atherosclerotic plaques using the stabilin-2-targeted tracer <sup>18</sup>F-S2P in preclinical models.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Glucagon-like peptide-1 receptor PET in indolent and aggressive insulinoma: Diagnostic performance, quantitative differences, and clinical implications.

European journal of nuclear medicine and molecular imaging·2026
Same journal

AI-based tumor and organ volumetry predicts early progression after Y-90 radioembolization in liver-dominant metastatic disease.

European journal of nuclear medicine and molecular imaging·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

Kinetic modelling of [11C]flumazenil using data-driven methods.

Isabelle Miederer1, Sibylle I Ziegler, Christoph Liedtke

  • 1Department of Nuclear Medicine, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. isabelle.miederer@tum.de

European Journal of Nuclear Medicine and Molecular Imaging
|December 2, 2008
PubMed
Summary
This summary is machine-generated.

Spectral analysis (SA), Logan graphical analysis (LGA), and multilinear reference tissue model 2 (MRTM2) accurately quantify benzodiazepine receptor binding with [11C]flumazenil (FMZ). These methods offer less invasive alternatives to traditional compartmental models.

More Related Videos

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941
09:50

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941

Published on: April 28, 2019

Related Experiment Videos

Last Updated: Jun 27, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941
09:50

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941

Published on: April 28, 2019

Area of Science:

  • Neuroscience
  • Radiochemistry
  • Nuclear Medicine

Background:

  • [(11)C]Flumazenil (FMZ) is a key radiotracer for positron emission tomography (PET) imaging of central-type gamma-aminobutyric acid (GABA-A) benzodiazepine receptors.
  • The validated invasive one-tissue (1T) compartmental model requires arterial input function analysis, which is invasive and complex.
  • Developing noninvasive, data-driven methods for FMZ analysis is crucial for broader clinical application and reduced patient burden.

Purpose of the Study:

  • To compare the accuracy of several noninvasive, data-driven methods (Logan graphical analysis [LGA], multilinear reference tissue model 2 [MRTM2], spectral analysis [SA], basis pursuit denoising [BPD]) against the invasive 1T compartmental model for quantifying [(11)C]FMZ binding.
  • To evaluate the feasibility of reducing PET scan duration from 90 to 60 minutes while maintaining data quality.
  • To assess the utility of using the pons as a reference tissue, eliminating the need for arterial blood sampling.

Main Methods:

  • Dynamic PET scans were performed on seven healthy volunteers with arterial blood sampling.
  • Noninvasive methods including SA, LGA (with and without arterial input), MRTM2, and BPD were applied.
  • Distribution volume ratios (DVRs) were calculated and compared across all methods, using the pons as reference tissue.

Main Results:

  • SA, LGA, and MRTM2 demonstrated strong agreement with the 1T model's DVR values.
  • Both invasive and noninvasive BPD showed slightly lower correlation with the 1T model.
  • A 60-minute scan protocol yielded useful data, though a 90-minute protocol provided superior performance based on coefficient of variation, correlation, and bias analyses.

Conclusions:

  • Spectral analysis (SA), Logan graphical analysis (LGA), and multilinear reference tissue model 2 (MRTM2) are validated, noninvasive methods for quantifying [(11)C]FMZ binding.
  • These methods offer a viable alternative to invasive arterial input function analysis, potentially reducing procedural invasiveness.
  • The 60-minute scan protocol provides a useful compromise between data acquisition time and quantitative accuracy for [(11)C]FMZ PET imaging.